SVFC $$$$ Nice deal for SVFC considering AREF is providing the clinical location and medical equipment, client/patient source/data and referrals, as well as the physicians and staffing,...and data/documentation for the FDA IND....as well as the $2500.00 per procedure fee to be paid to SVFC by AREF!
If I read your post correctly, they don't receive the monthly cash payments until the increase in capital is raised for SVFC? Therefore, the only cost at this point is the issuance of a few million shares of stock? I recognize that it is considered dilution (minimal), but not too bad considering the potential to raise a ton of cash. If they raise 15 million, that would allow them to pay off the toxic debt.